Analytics

Articles

GlobalData reports the need to shift away from egg-based manufacturing of vaccines in light of influenza-related deaths.

GlobalData Reports Need to Shift to Newer Vaccine Manufacturing Technologies

Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.

ProBioGen and Surface Oncology Sign Second Antibody Manufacturing Program

The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.

AstraZeneca to Create Independent Biotech Spin-Off

The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.

Novo Nordisk Publishes New Study on Bioproduction of Chemicals

Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification. 

ADC Bio to Develop New Bioconjugation Process

Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.

J&J and Theravance in $1-Billion Deal for Inflammatory Bowel Disease

Fabia Gozzo, PhD, is CEO of Excelsus Structural Solutions, www.excelsusSS.com. With more than 25 years of experience at synchrotron facilities, she has constructed and developed a state-of-the-art powder diffractometer at the Swiss Light Source before founding Excelsus Structural Solutions, a spin-off company that provides synchrotron radiation based analytical services to the pharmaceutical and chemical industry.

X-ray powder diffraction exploits the interaction between x-rays and matter to study the structural and microstructural properties of materials. 

The Power of Synchrotron X-Ray Powder Diffraction for the Characterization of Pharmaceuticals

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.

Impurity Testing

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics. 

Bigger is Better in Samsung's Approach to Biomanufacturing

The new Acquity Arc Bio System by Waters is specifically engineered to enable efficient transfer and improvement of bioseparation analytical methods.

Drug Substance Analysis